Evidence map›Paper›PMID 42049662›Full record

ArticleBJU international2026

'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

Vignesh T Packiam, Peter C Black, James W F Catto, Saum Ghodoussipour, Max Kates, Ashish M Kamat, Yair Lotan, Michael A O'Donnell, Jeremy Y C Teoh, George N Thalmann and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vignesh T PackiamRutgers Cancer Institute, New Brunswick, NJ, USA.ORCID https://orcid.org/0000-0001-8397-7797
Peter C BlackUniversity of British Columbia, Vancouver, British Colombia, Canada.
James W F CattoUniversity of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0003-2787-8828
Saum GhodoussipourRutgers Cancer Institute, New Brunswick, NJ, USA.
Max KatesJohns Hopkins University, Baltimore, MD, USA.
Ashish M KamatThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yair LotanUT Southwestern Medical Center, Dallas, TX, USA.ORCID https://orcid.org/0000-0001-5692-2723
Michael A O'DonnellUniversity of Iowa, Iowa City, IA, USA.ORCID https://orcid.org/0000-0001-7202-6427
Jeremy Y C TeohThe Chinese University of Hong Kong, Hong Kong, China.ORCID https://orcid.org/0000-0002-9361-2342
George N ThalmannUniversity Hospital of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0002-1908-3286
Stephen B WilliamsThe University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0002-2683-2185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42049662
PMCPMC13244588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.